[{"id":"3d66fb01-02f1-45d0-87e9-a2ed40578b6a","acronym":"","url":"https://clinicaltrials.gov/study/NCT05618327","created_at":"2022-11-16T18:56:46.106Z","updated_at":"2024-07-02T16:35:41.295Z","phase":"Phase 1","brief_title":"Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma","source_id_and_acronym":"NCT05618327","lead_sponsor":"Shanghai Junshi Bioscience Co., Ltd.","biomarkers":" CD20 • IL6 • IL2 • IL10","pipe":" | ","alterations":" CD20 expression","tags":["CD20 • IL6 • IL2 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JS203"],"overall_status":"Recruiting","enrollment":" Enrollment 219","initiation":"Initiation: 02/13/2023","start_date":" 02/13/2023","primary_txt":" Primary completion: 12/24/2024","primary_completion_date":" 12/24/2024","study_txt":" Completion: 02/22/2025","study_completion_date":" 02/22/2025","last_update_posted":"2023-08-01"}]